Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Emeritus Professor Paul Corris

Newcastle AuthorsTitleYearFull text
Emeritus Professor Paul Corris
Application of the REVEAL risk score calculator 2.0 in the PATENT study2021
Emeritus Professor Paul Corris
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry2021
Emeritus Professor Paul Corris
Dr James Lordan
A European Multi-Center, Randomized, Double-Blind Trial of Pirfenidone in Bronchiolitis-Obliterans-Syndrome Grade 1-3 in Lung Transplant Recipients (European Trial of Pirfenidone in BOS (EPOS))2020
Emeritus Professor Paul Corris
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension2020
Emeritus Professor Paul Corris
Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute2020
Emeritus Professor Paul Corris
Clinical trial design in phase 2 and 3 trials for pulmonary hypertension2020
Emeritus Professor Paul Corris
Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE2020
Emeritus Professor Paul Corris
Professor Andrew Fisher
Dr James Lordan
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?2020
Emeritus Professor Paul Corris
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension2020
Emeritus Professor Paul Corris
Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH2020
1234567891011121314151617181920...